Question 1

What is Xia Yu?

Accepted Answer

Xia Yu is a Person.

Question 2

How often does Xia Yu appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Xia Yu first tracked by Ergen?

Accepted Answer

First tracked on Jun 12, 2026.

Question 4

When was Xia Yu last mentioned in news?

Accepted Answer

Last active on Jun 12, 2026.

Question 5

What is Xia Yu's current news sentiment?

Accepted Answer

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Xia Yu in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Xia Yu?

Accepted Answer

Akeso's gumokimab approved in China (Jun 12, 2026, 7 articles).

Question 8

How did the "Akeso's gumokimab approved in China" event impact Xia Yu?

Accepted Answer

Xia Yu, Founder, Chairwoman, President and CEO of Akeso, expressed gratitude to the study participants and highlighted Akeso's growing portfolio in autoimmune diseases.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.